IRulya Therapeutics (QNCX)
IRulya Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
60K
Short interest
settlement 2026-09-30
2.7
Days to cover
-0.3 days vs prior
41.3%
Short share of volume
2026-10-09
203
Fails to deliver
settlement 2026-10-08
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-14.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in QNCX is 59,944 shares, up 2,955 shares over the last month. Over the last 48 readings it ranged from 50,273 shares (15 September 2026) to 13,826,556 shares (31 March 2026). The latest reading sits at the bottom of that range. At the reported average volume of 22K shares a day that is 2.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/qncx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 59,944 | +19.2% | 22,463 | 2.67 |
| 2026-09-15 | 50,273 | -11.8% | 16,765 | 3.00 |
| 2026-08-31 | 56,989 | -5.5% | 21,437 | 2.66 |
| 2026-08-14 | 60,277 | +6.4% | 34,902 | 1.73 |
| 2026-07-31 | 56,631 | +12.0% | 37,331 | 1.52 |
| 2026-07-15 | 50,574 | -55.2% | 42,759 | 1.18 |
| 2026-06-30 | 112,788 | -94.4% | 23,583 | 4.78 |
| 2026-06-15 | 2,012,417 | -2.3% | 601,724 | 3.34 |
| 2026-05-29 | 2,059,788 | +17.2% | 3,488,377 | 1.00 |
| 2026-05-15 | 1,758,167 | -1.5% | 767,529 | 2.29 |
| 2026-04-30 | 1,784,949 | -8.6% | 1,660,677 | 1.07 |
| 2026-04-15 | 1,951,816 | -85.9% | 21,241,546 | 1.00 |
| 2026-03-31 | 13,826,556 | +24.0% | 27,231,626 | 1.00 |
| 2026-03-13 | 11,153,033 | +34.4% | 47,078,857 | 1.00 |
| 2026-02-27 | 8,298,192 | -19.7% | 41,372,336 | 1.00 |
| 2026-02-13 | 10,338,418 | +451.1% | 284,154,407 | 1.00 |
| 2026-01-30 | 1,875,868 | -45.7% | 6,834,214 | 1.00 |
| 2026-01-15 | 3,454,280 | +31.9% | 1,046,808 | 3.30 |
| 2025-12-31 | 2,617,907 | +26.8% | 500,623 | 5.23 |
| 2025-12-15 | 2,064,545 | +33.0% | 1,208,667 | 1.71 |
| 2025-11-28 | 1,551,992 | +13.6% | 1,095,710 | 1.42 |
| 2025-11-14 | 1,365,905 | +4.2% | 506,406 | 2.70 |
| 2025-10-31 | 1,311,476 | -0.9% | 209,883 | 6.25 |
| 2025-10-15 | 1,324,098 | +48.5% | 582,225 | 2.27 |
| 2025-09-30 | 891,442 | +2.1% | 264,232 | 3.37 |
| 2025-09-15 | 872,756 | -2.5% | 118,494 | 7.37 |
| 2025-08-29 | 894,885 | -3.7% | 121,676 | 7.35 |
| 2025-08-15 | 929,118 | +4.8% | 260,923 | 3.56 |
| 2025-07-31 | 886,689 | +19.7% | 166,506 | 5.33 |
| 2025-07-15 | 740,893 | +64.5% | 275,938 | 2.68 |
| 2025-06-30 | 450,357 | -5.0% | 309,580 | 1.45 |
| 2025-06-13 | 473,979 | -6.5% | 343,180 | 1.38 |
| 2025-05-30 | 506,936 | -16.2% | 197,132 | 2.57 |
| 2025-05-15 | 604,945 | -42.7% | 937,401 | 1.00 |
| 2025-04-30 | 1,055,950 | -25.5% | 112,747 | 9.37 |
| 2025-04-15 | 1,416,916 | -7.7% | 154,727 | 9.16 |
| 2025-03-31 | 1,535,782 | -9.2% | 109,262 | 14.06 |
| 2025-03-14 | 1,691,150 | -33.4% | 146,782 | 11.52 |
| 2025-02-28 | 2,538,037 | -1.1% | 82,500 | 30.76 |
| 2025-02-14 | 2,566,046 | -3.1% | 128,707 | 19.94 |
| 2025-01-31 | 2,649,255 | +2.0% | 113,583 | 23.32 |
| 2025-01-15 | 2,598,300 | +8.3% | 142,347 | 18.25 |
| 2024-12-31 | 2,398,013 | +0.2% | 173,310 | 13.84 |
| 2024-12-13 | 2,394,137 | +10.2% | 252,184 | 9.49 |
| 2024-11-29 | 2,173,163 | +21.3% | 307,844 | 7.06 |
| 2024-11-15 | 1,792,133 | -23.6% | 418,682 | 4.28 |
| 2024-10-31 | 2,345,565 | +22.7% | 2,018,655 | 1.16 |
| 2024-10-15 | 1,911,224 | -0.5% | 31,974 | 59.77 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of QNCX volume is 41.3%, down 37.3 points over the last five sessions. Over the last 30 readings it ranged from 17.6% (3 September 2026) to 83.2% (4 September 2026). The latest reading is 15.1 points below the 30-session average of 56.5%, on 45K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 19K | 45K | 41.3% | 55 |
| 2026-10-08 | 3K | 5K | 66.0% | 0 |
| 2026-10-07 | 442 | 1K | 36.7% | 0 |
| 2026-10-06 | 769 | 2K | 33.1% | 0 |
| 2026-10-05 | 1K | 4K | 41.0% | 0 |
| 2026-10-02 | 6K | 8K | 78.6% | 0 |
| 2026-10-01 | 2K | 4K | 55.3% | 0 |
| 2026-09-30 | 889 | 2K | 49.8% | 0 |
| 2026-09-29 | 4K | 7K | 55.4% | 205 |
| 2026-09-28 | 11K | 13K | 81.6% | 7 |
| 2026-09-25 | 487 | 2K | 30.9% | 0 |
| 2026-09-24 | 1K | 2K | 81.7% | 0 |
| 2026-09-23 | 2K | 2K | 75.3% | 199 |
| 2026-09-22 | 6K | 10K | 67.0% | 3 |
| 2026-09-21 | 3K | 4K | 61.9% | 0 |
| 2026-09-18 | 9K | 12K | 78.8% | 0 |
| 2026-09-17 | 923 | 3K | 34.0% | 36 |
| 2026-09-16 | 9K | 14K | 61.0% | 85 |
| 2026-09-15 | 4K | 6K | 61.7% | 100 |
| 2026-09-14 | 6K | 7K | 79.6% | 0 |
| 2026-09-11 | 2K | 3K | 61.0% | 0 |
| 2026-09-10 | 695 | 2K | 30.7% | 0 |
| 2026-09-09 | 1K | 2K | 72.7% | 0 |
| 2026-09-08 | 2K | 5K | 46.1% | 0 |
| 2026-09-04 | 16K | 19K | 83.2% | 3 |
| 2026-09-03 | 1K | 6K | 17.6% | 1 |
| 2026-09-02 | 1K | 2K | 53.9% | 0 |
| 2026-09-01 | 2K | 4K | 60.6% | 0 |
| 2026-08-31 | 1K | 5K | 27.5% | 0 |
| 2026-08-28 | 5K | 8K | 69.7% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 October 2026, the fails-to-deliver balance in QNCX is 203 shares, down 666 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (11 September 2026) to 3,720 shares (19 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-08 | 203 | $26.72 | $5K |
| 2026-10-01 | 869 | $31.01 | $27K |
| 2026-09-30 | 1,387 | $31.17 | $43K |
| 2026-09-29 | 141 | $29.00 | $4K |
| 2026-09-28 | 131 | $30.40 | $4K |
| 2026-09-23 | 105 | $31.35 | $3K |
| 2026-09-21 | 1,117 | $29.48 | $33K |
| 2026-09-16 | 1 | $28.85 | $29 |
| 2026-09-11 | 1 | $28.96 | $29 |
| 2026-09-09 | 7 | $29.50 | $207 |
| 2026-09-08 | 373 | $31.32 | $12K |
| 2026-09-02 | 708 | $32.14 | $23K |
| 2026-08-31 | 1,392 | $33.75 | $47K |
| 2026-08-28 | 610 | $32.50 | $20K |
| 2026-08-27 | 5 | $31.31 | $157 |
| 2026-08-24 | 4 | $33.93 | $136 |
| 2026-08-20 | 2,373 | $34.57 | $82K |
| 2026-08-19 | 3,720 | $32.91 | $122K |
| 2026-08-17 | 935 | $34.04 | $32K |
| 2026-08-14 | 1,033 | $32.41 | $33K |
| 2026-08-12 | 1,520 | $32.73 | $50K |
| 2026-08-11 | 179 | $30.65 | $5K |
| 2026-08-06 | 1,036 | $28.88 | $30K |
| 2026-08-05 | 600 | $27.41 | $16K |
| 2026-08-04 | 495 | $24.97 | $12K |
| 2026-08-03 | 2,007 | $23.39 | $47K |
| 2026-07-31 | 2,739 | $23.03 | $63K |
| 2026-07-29 | 947 | $19.37 | $18K |
| 2026-07-28 | 1,584 | $17.85 | $28K |
| 2026-07-27 | 259 | $17.86 | $5K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for QNCX in the last 90 days. The most recent filings are listed below. Latest filing: Benatti Luca (Director) on 2025-12-26.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2025-12-26 | Benatti Luca | Director | Sell | 50K | $3.47 | $174K | 39K |
| 2025-12-10 | Thye Dirk | CEO and CMO | Gift | 740K | $0.00 | $0 | 740K |
| 2025-12-10 | Thye Dirk | CEO and CMO | Gift | 740K | $0.00 | $0 | 255K |
| 2025-12-05 | Hannah Brendan | CBO, COO & CCO | Exercise or conversion | 25K | $0.94 | $24K | 362K |
| 2025-12-05 | Hannah Brendan | CBO, COO & CCO | Exercise or conversion | 2K | $0.55 | $1K | 337K |
| 2025-06-18 | Ryan Charles S. | President | Grant | 8K | $1.20 | $9K | 130K |
| 2025-06-18 | Thye Dirk | CEO and CMO | Grant | 151K | $1.20 | $181K | 995K |
| 2025-06-18 | Hannah Brendan | CBO, COO & CCO | Grant | 38K | $1.20 | $45K | 334K |
| 2024-10-23 | Benatti Luca | Director | Other transaction | 9K | price not stated in the filing | not stated | 89K |
| 2024-08-30 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | Buy | 77K | $0.70 | $54K | 844K |
| 2024-08-29 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | Buy | 78K | $0.69 | $53K | 767K |
| 2024-08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 5K | $0.62 | $3K | 273K |
| 2024-08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 2K | $0.61 | $1K | 268K |
| 2024-08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 24K | $0.63 | $15K | 297K |
| 2024-08-20 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 3K | $0.60 | $2K | 266K |
| 2024-08-20 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 3K | $0.61 | $2K | 262K |
| 2024-08-20 | Ryan Charles S. | PRESIDENT | Buy | 48K | $0.65 | $31K | 122K |
| 2024-08-19 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy | 2K | $0.58 | $1K | 260K |
| 2024-06-04 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Exercise or conversion | 56K | $0.55 | $31K | 258K |
| 2024-01-16 | Thye Dirk | CHIEF EXECUTIVE OFFICER | Exercise or conversion | 91K | $0.55 | $50K | 539K |
| 2024-01-16 | Thye Dirk | CHIEF EXECUTIVE OFFICER | Exercise or conversion | 150K | $0.94 | $141K | 689K |
| 2023-12-14 | Lamond David | Director | Buy | 23K | $1.04 | $24K | 2.3M |
| 2023-12-13 | Lamond David | Director | Buy | 23K | $1.00 | $23K | 2.3M |
| 2023-12-12 | Lamond David | Director | Buy | 22K | $1.02 | $23K | 2.3M |
| 2023-12-12 | Lamond David | Director | Buy | 300 | $1.00 | $300 | 2.3M |
| 2023-12-07 | Lamond David | Director | Buy | 19K | $1.01 | $19K | 2.3M |
| 2023-12-06 | Lamond David | Director | Buy | 19K | $1.02 | $20K | 2.3M |
| 2023-12-05 | Lamond David | Director | Buy | 19K | $1.01 | $19K | 2.2M |
| 2023-12-01 | Lamond David | Director | Buy | 14K | $0.94 | $14K | 2.2M |
| 2023-11-30 | Lamond David | Director | Buy | 14K | $0.90 | $13K | 2.2M |
| 2023-11-29 | Lamond David | Director | Buy | 14K | $0.98 | $14K | 2.2M |
| 2023-08-31 | Lamond David | Director | Buy | 41K | $1.32 | $54K | 2.2M |
| 2023-08-30 | Lamond David | Director | Buy | 41K | $1.31 | $54K | 2.1M |
| 2023-08-17 | Lamond David | Director | Buy | 25K | $1.29 | $32K | 2.1M |
| 2023-08-16 | Lamond David | Director | Buy | 117K | $1.29 | $151K | 2.1M |
| 2023-08-15 | Lamond David | Director | Buy | 108K | $1.32 | $142K | 2.0M |
| 2023-08-10 | Thye Dirk | Chief Executive Officer | Buy | 88K | $1.26 | $111K | 449K |
| 2023-08-08 | McLoughlin Margaret | Director | Buy | 8K | $1.23 | $10K | 8K |
| 2023-08-08 | Hannah Brendan | Chief Business Officer | Buy | 72K | $1.22 | $88K | 202K |
| 2023-08-08 | Thye Dirk | Chief Executive Officer | Buy | 80K | $1.24 | $99K | 361K |
| 2023-03-06 | Monohon Ted | Chief Accounting Officer & VP | Sell | 2K | $0.98 | $2K | 27K |
| 2022-12-05 | Monohon Ted | Chief Accounting Officer & VP | Tax withholding | 2K | $0.72 | $1K | 29K |
| 2022-09-06 | Monohon Ted | Chief Accounting Officer & VP | Tax withholding | 2K | $1.64 | $2K | 31K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for QNCX worth $173K at the prices reported; 0 in the last 90 days worth $0. Latest: LUCA BENATTI filed on 2025-12-29 to sell 50,000 shares ($173K) from 2025-12-26.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2025-12-29 | LUCA BENATTIOFFICER | 50K | $173K | 0.090% | 2025-12-26 | MERRILL |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON22 holders report 5% or more of QNCX in their latest filing, all on Schedule 13G (passive). The largest reported stake is GROUP ONE TRADING LLC at 10.7% of the class (5,942,906 shares), filed 2026-03-05 for an event on 2026-02-28.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-14 | 13G | Joseph Edelmanindividual | 913K | 8.4% | 2026-10-06 |
| 2026-10-14 | 13G | Perceptive Advisors LLCinvestment adviser | 913K | 8.4% | 2026-10-06 |
| 2026-10-14 | 13G | Perceptive Life Sciences Master Fund, Ltd.corporation | 913K | 8.4% | 2026-10-06 |
| 2026-10-14 | 13G | James B. Tananbaumindividual | 652K | 6.0% | 2026-10-06 |
| 2026-10-14 | 13G | Foresite Capital Management VI, LLCother entity | 489K | 4.5% | 2026-10-06 |
| 2026-10-14 | 13G | Foresite Capital Fund VI LPpartnership | 489K | 4.5% | 2026-10-06 |
| 2026-10-14 | 13G | Foresite Public & Crossover Opportunities Management I, LLCother entity | 163K | 1.5% | 2026-10-06 |
| 2026-10-14 | 13G | Foresite Public & Crossover Opportunities Fund I, L.P.partnership | 163K | 1.5% | 2026-10-06 |
| 2026-08-14 | 13G | Neil Shahrestaniindividual, parent holding company | 92K | 9.0% | 2026-06-30 |
| 2026-08-14 | 13G | Ikarian Capital, LLCinvestment adviser | 92K | 9.0% | 2026-06-30 |
| 2026-08-14 | 13G | Cormorant Asset Management, LPinvestment adviser, partnership | 108K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | Bihua Chenparent holding company, individual | 108K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | BALYASNY ASSET MANAGEMENT L.P.investment adviser, partnership | 98K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | BAM GP LLCparent holding company, other entity | 98K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | Balyasny Asset Management Holdings LPparent holding company, partnership | 98K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | Dames GP LLCparent holding company, other entity | 98K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G | Dmitry Balyasnyparent holding company, individual | 98K | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Nantahala Capital Management, LLCinvestment adviser | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Wilmot B. Harkeyparent holding company | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Daniel Mackparent holding company | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G | Squadron Master Fund LPpartnership | 55K | 5.6% | 2026-07-28 |
| 2026-08-04 | 13G | Squadron Capital Management LLCinvestment adviser, parent holding company | 55K | 5.6% | 2026-07-28 |
| 2026-08-04 | 13G | Matthew Sesterhennparent holding company, individual | 55K | 5.6% | 2026-07-28 |
| 2026-08-04 | 13G | William Blankparent holding company, individual | 55K | 5.6% | 2026-07-28 |
| 2026-06-10 | 13G | Israel A. Englanderindividual | 1.4M | 7.2% | 2026-06-04 |
| 2026-06-10 | 13G | Millennium Group Management LLCother entity | 1.4M | 7.2% | 2026-06-04 |
| 2026-06-10 | 13G | Millennium Management LLCother entity | 1.4M | 7.2% | 2026-06-04 |
| 2026-06-10 | 13G | Integrated Core Strategies (US) LLCother entity | 1.4M | 7.2% | 2026-06-04 |
| 2026-03-05 | 13G | GROUP ONE TRADING LLCbroker-dealer | 5.9M | 10.7% | 2026-02-28 |
| 2025-10-30 | 13G/Ano. 2 | Genextra S.p.A.other entity | 0 | 0.0% | 2025-07-07 |
| 2025-10-30 | 13G/Ano. 2 | Francesco Micheliindividual | 0 | 0.0% | 2025-07-07 |
| 2025-10-30 | 13G/Ano. 2 | Matteo Bruno Renzulliindividual | 0 | 0.0% | 2025-07-07 |
13F holders
Tracked managers holding QNCX at their latest 13F. JSON1 of the 30 tracked managers held QNCX at their latest 13F, $1.3M in total at quarter-end prices. Millennium Management is the largest at $1.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 71K | $1.3M | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
IRulya Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows IRulya Therapeutics (QNCX), SEC CIK 1662774, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-12-29.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-12-26.JSON and CSV
- Company record
- EDGAR filing index for CIK 1662774Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- TKOTKO Group Holdings
- TLNTalen Energy
- TMOThermo Fisher Scientific
- TMUST-Mobile US
- TNONTenon Medical
- TOLToll Brothers
- TOSTToast
- TPGTPG
- TPLTexas Pacific Land
- TPRTapestry
- TRGPTarga Resources
- TRIThomson Reuters
- TRMBTrimble
- TROWT. Rowe Price
- TRPTC Energy
- TRUTransUnion
- TRVTravelers Companies
- TSCOTractor Supply
- TSEMTower Semiconductor
- TSLATesla
- TSMTaiwan Semiconductor Manufacturing
- TSNTyson Foods
- TTTrane Technologies
- TTANServiceTitan
Datasets
Frequently Asked Questions
How much of QNCX is sold short?
What is QNCX's daily short volume?
Does QNCX have fails to deliver?
Are QNCX insiders buying or selling?
Have QNCX insiders filed to sell?
Who owns 5% or more of QNCX?
Which tracked 13F managers own QNCX?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.